Targeting PID1 generates oxysterols to switch macrophage cell fates for improved antitumor immunity

de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374–403 (2023).

Article  PubMed  Google Scholar 

Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887–904 (2018).

Article  CAS  PubMed  Google Scholar 

Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49–61 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goossens, P. et al. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metab. 29, 1376–1389 (2019).

Article  CAS  PubMed  Google Scholar 

Gordon, S. & Martinez, F. O. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593–604 (2010).

Article  CAS  PubMed  Google Scholar 

Grzywa, T. M. et al. Myeloid cell-derived arginase in cancer immune response. Front. Immunol. 11, 938 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thommen, D. S. & Schumacher, T. N. T cell dysfunction in cancer. Cancer Cell 33, 547–562 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arner, E. N. & Rathmell, J. C. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41, 421–433 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Renne, M. F. & Hariri, H. Lipid droplet–organelle contact sites as hubs for fatty acid metabolism, trafficking, and metabolic channeling. Front. Cell Dev. Biol. 9, 726261 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Song, Y., Liu, J., Zhao, K., Gao, L. & Zhao, J. Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases. Cell Metab. 33, 1911–1925 (2021).

Article  CAS  PubMed  Google Scholar 

Di Conza, G. et al. Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity. Nat. Immunol. 22, 1403–1415 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Bidault, G. et al. SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation. Nat. Metab. 3, 1150–1162 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoppstadter, J. et al. Dysregulation of cholesterol homeostasis in human lung cancer tissue and tumour-associated macrophages. EBioMedicine 72, 103578 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Sag, D., Cekic, C., Wu, R., Linden, J. & Hedrick, C. C. The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity. Nat. Commun. 6, 6354 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao, J. et al. 25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages. Immunity 57, 1087–1104 (2024).

Article  CAS  PubMed  Google Scholar 

Xu, J. et al. PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB. Sci. Rep. 7, 835 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Erdreich-Epstein, A. et al. PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas. Clin. Cancer Res. 20, 827–836 (2014).

Article  CAS  PubMed  Google Scholar 

Yang, J. et al. Dual role of PID1 in regulating apoptosis induced by distinct anticancer-agents through AKT/Raf-1-dependent pathway in hepatocellular carcinoma. Cell Death Discov. 9, 139 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Fischer, A. W. et al. The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins. Mol. Metab. 16, 88–99 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu, X. et al. A gut-derived hormone regulates cholesterol metabolism. Cell 187, 1685–1700 (2024).

Article  CAS  PubMed  Google Scholar 

Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442–459 (2020).

Article  CAS  PubMed  Google Scholar 

Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829–845 (2019).

Article  CAS  PubMed  Google Scholar 

Jing, X. et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol. Cancer 18, 157 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Finicle, B. T., Jayashankar, V. & Edinger, A. L. Nutrient scavenging in cancer. Nat. Rev. Cancer 18, 619–633 (2018).

Article  CAS  PubMed  Google Scholar 

DePeaux, K. & Delgoffe, G. M. Metabolic barriers to cancer immunotherapy. Nat. Rev. Immunol. 21, 785–797 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdel-Latif, M. M. et al. NF-κB activation in esophageal adenocarcinoma: relationship to Barrett’s metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann. Surg. 239, 491–500 (2004).

Article  PubMed  PubMed Central  Google Scholar 

DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369–382 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang, J. et al. Outer membrane vesicle-based nanohybrids target tumor-associated macrophages to enhance trained immunity-related vaccine-generated antitumor activity. Adv. Mater. 35, e2306158 (2023).

Article  PubMed  Google Scholar 

Thaker, A. I., Shaker, A., Rao, M. S. & Ciorba, M. A. Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS). J. Vis. Exp. (67), e4100 (2012).

Dzhalilova, D., Zolotova, N., Fokichev, N. & Makarova, O. Murine models of colorectal cancer: the azoxymethane (AOM)/dextran sulfate sodium (DSS) model of colitis-associated cancer. PeerJ 11, e16159 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Ho, C. et al. AKT (v-Akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma Ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. Hepatology 55, 833–845 (2012).

Article  CAS  PubMed  Google Scholar 

Klinke, D. J. II, Gould, A., Pirkey, A., Razazan, A. & Deng, W. A functional comparison of two transplantable syngeneic mouse models of melanoma: B16F0 and YUMM1.7. Biol. Open 14, bio062175 (2025).

Mantovani, A., Allavena, P., Marchesi, F. & Garlanda, C. Macrophages as tools and targets in cancer therapy. Nat. Rev. Drug Discov. 21, 799–820 (2022).

Comments (0)

No login
gif